| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein …
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/3/264:00 PM | -$0.19 | -$0.19GAAP | 0.0% | — | $30.2M | $33.6M | +11.2% | — | |
| Q2 '26 | 8/10/264:00 PM | -$0.33 | -$0.22GAAP | +33.3% | — | $26.0M | $29.4M | +13.4% | — | |
| Q1 '26 | 5/8/268:00 AM | — | -$1.74GAAP | — | — | — | $26.0M | — | — |
GAAP = diluted EPS as filed with the SEC.